Newsgroups Main » Newsgroups Directory » Science and Technology

Cryonics ( sci.cryonics )
spacer NewsDemon Usenet 2021 Access
 
From [email protected] Thu May 21 11:37:55 1992 Xref: uunet news.announce.newgroups:2368 news.groups:51287 sci.nanotech:1573 sci.med:37945 sci.med.aids:4321 Newsgroups: news.announce.newgroups,news.groups,sci.nanotech,sci.med,sci.med.aids Path: uunet!uunet!news.claremont.edu!ucivax!ucla-cs!usenet From: [email protected] (Kevin Q Brown) Subject: RFD: sci.cryonics Message-ID: <[email protected]> Followup-To: news.groups Note: non-commercial reproduction. Keywords: cryonics, biostasis, suspended animation, nanotechnology Sender: [email protected] (Mr Usenet) Nntp-Posting-Host: sole.cs.ucla.edu Archive-Number: 5421 Organization: AT&T Bell Laboratories Date: Tue, 19 May 92 21:41:55 EDT Approved: [email protected]  Lines: 65  Request for Discussion:    Proposed group: sci.cryonics    Status: Moderated (proposed moderator: Kevin Q. Brown)    Followup: news.groups  Purpose:      Cryonic suspension is an experimental procedure whereby patients     who can no longer be kept alive with today's medical abilities are     preserved at low temperature for treatment in the future.     This newsgroup will be the place to keep up-to-date on topics related     to cryonics, which include biochemistry of memory, low temperature     biology, new cryonics-related research and publications, legal status     of cryonics and cryonically suspended people, nanotechnology and cell     repair machines, mass media coverage of cryonics, conferences, and     local cryonics group meetings.  Rationale:      A cryonics mailing list (moderated by Kevin Q. Brown) has been     running for almost four years and the mailing list size and     message frequency now have reached "critical mass" for forming a     USENET news group.  Reaching a wider audience is important for     two reasons:       (1) we have found that a small, but significant, percentage 	  of the population is looking for something like a newsgroup 	  on cryonics but does not know where to look and       (2) cryonics needs a lot of research, critical thought, 	  skilled and knowledgeable communication, and other support 	  to succeed, and everyone will benefit from its success.  Naming:      Would another newsgroup name be better?  For example, some people     prefer sci.med.cryonics because a cryonic suspension is, more     than anything else, a medical procedure.  Others, noting that     reanimation from cryonic suspension cannot succeed without     advanced nanotechnology, prefer sci.nanotech.cryonics.  Since the     practice of cryonics is so inter-disciplinary, however, most prefer     simply sci.cryonics.  Other people, referring to the currently     controversial status of cryonics, prefer a name outside the     sci.* hierarchy altogether.  Discussion Period:      The discussion period will be at most one month and at least two     weeks (depending on how quickly we resolve our questions about     the proposed group sufficiently for producing a Call For Votes).  Acknowledgements      Many people have contributed their thoughts on creating a USENET     cryonics newsgroup.  In particular, my thanks (in alphabetical     order by last name) to:       Keith Henson         ([email protected])       Perry Metzger        ([email protected])       Russell Whitaker     ([email protected])     Of course, any errors in this message are mine.  			       Kevin Q. Brown 			       UUCP        ...att!whscad1!kqb 			       INTERNET    [email protected]  From [email protected] Thu Jun 11 14:29:49 1992 Xref: uunet news.announce.newgroups:2411 news.groups:52315 sci.nanotech:1634 sci.med:39191 sci.med.aids:4401 Newsgroups: news.announce.newgroups,news.groups,sci.nanotech,sci.med,sci.med.aids Path: uunet!uunet!elroy.jpl.nasa.gov!ucla-cs!usenet From: [email protected] (Kevin Q Brown) Subject: CFV: sci.cryonics Message-ID: <[email protected]> Followup-To: poster Note: non-commercial reproduction. Keywords: cryonics, biostasis, suspended animation Sender: [email protected] (Mr Usenet) Nntp-Posting-Host: sole.cs.ucla.edu Archive-Number: 5509 Organization: AT&T Bell Laboratories Date: Mon,  8 Jun 92 19:36:13 EDT Approved: [email protected]  Lines: 69  Call For Votes:    Proposed group: sci.cryonics    Status: Unmoderated    Voting Period: June 8, 1992 - June 30, 1992 Eastern Daylight Time  Charter:      Cryonic suspension is an experimental procedure whereby patients     who can no longer be kept alive with today's medical abilities are     preserved at low temperature for treatment in the future.     This newsgroup will be the place to keep up-to-date on topics related     to cryonics, which include biochemistry of memory, low temperature     biology, new cryonics-related research and publications, legal status     of cryonics and cryonically suspended people, nanotechnology and cell     repair machines, mass media coverage of cryonics, conferences, and     local cryonics group meetings.  Rationale:      A cryonics mailing list (moderated by Kevin Q. Brown) has been     running for almost four years and the mailing list size and     message frequency now have reached "critical mass" for forming a     USENET news group.  Reaching a wider audience is important for     two reasons:       (1) we have found that a number of people have been looking for           something like a newsgroup on cryonics but do not know where           to look and       (2) cryonics needs a lot of research, critical thought, 	  skilled and knowledgeable communication, and other support 	  to succeed, and everyone will benefit from its success.  Voting Procedure:      Tim Freeman has kindly offered his services to do the vote counting.     To send a "yes" vote, send email to:          [email protected]      and to send a "no" vote, send email to:          [email protected]      The subject line and body of the email are ignored.  His software     will acknowledge your vote automatically, while also logging it for     his records.  If you vote more than once, only your last vote     received will be counted in the final tally.      Note: Please do not send your vote to me; use only the above two     addresses.  Also, be certain to send to the user id "tsf=yes" or     "tsf=no", exactly as written above, because the names "yes" and "no"     by themselves will not work.  If you do not receive an acknowledgment     within 24 hours, you may inquire at [email protected] to verify that the     vote was received.      DO NOT POST YOUR VOTE!  Posted votes will not be counted.  Voting Period:      All votes must be received by Tim Freeman at the above two addresses     before midnight June 30, 1992, Eastern Daylight Time.  (ie. The date     he receives the email must be in June, not July, in his local time.)     Any votes received in July will be discarded.  			       Kevin Q. Brown 			       UUCP        ...att!whscad1!kqb 			       INTERNET    [email protected]  From [email protected] Tue Jul  7 14:29:54 1992 Xref: uunet news.announce.newgroups:2502 news.groups:53815 sci.nanotech:1680 sci.med:41055 sci.med.aids:4516 Path: uunet!uunet!bounce-back From: [email protected] (Timothy Freeman) Newsgroups: news.announce.newgroups,news.groups,sci.nanotech,sci.med,sci.med.aids Subject: RESULT: sci.cryonics passes 205:58 Followup-To: news.groups Date: 2 Jul 1992 14:38:11 -0400 Organization: School of Computer Science, Carnegie Mellon University Lines: 272 Sender: [email protected] (David C Lawrence) Approved: [email protected] Message-ID: <[email protected]> Archive-Number: 5618  These are the results for the vote about creating sci.cryonics.  It passed, 205 to 58.  The votes appear below in alphabetical order.  There will now be a five day period during which people have a chance to find errors, repeated votes, missing votes, and other strange things in the list; the final tally will be announced on July 7, 1992.                                                       Yes votes: Adam Schenker (GE) <[email protected]> [email protected] "A.J. Clifford" <[email protected]> [email protected] ALAN BINNIE <[email protected]> [email protected] (Alan Smale) ALLEN SMITH [email protected]> Andreas Haug <[email protected]> Andrew Davidson <[email protected]> [email protected] (Anthony Napier) [email protected] (Stephanie da Silva) [email protected] (Arik Anderson) [email protected] (arthur rubin) "A.T." Fear <[email protected]> Bill McCormick <[email protected]> [email protected] (Joe Silva) [email protected] (Barb Moose) [email protected] (Brian A. Stewart) Bob Bickford <[email protected]> Bob Smart <[email protected]> Bob Yazz <[email protected]> [email protected] (Jeffrey Lind) [email protected] (A.Lizard) brenda peters <[email protected]> [email protected] (Brent J. Krawchuk) Brian Wowk <[email protected]> [email protected] (Brian Berndt) [email protected] (Patrick K. Bronson) Bruce White 3807 <[email protected]> [email protected] (Bob Smart) [email protected] (Charles Alan Daniel) [email protected] (Craig A. Leger) [email protected] [email protected] (Anthony J. Caruso) [email protected]*.MN.org (Chris Galas) "Charles.Hargraves" <[email protected]> [email protected] (Chris Cole) Clay Bridges <[email protected]> [email protected] (Jud Cooley) [email protected] (Mark Cox) [email protected] (David Gordon) [email protected] Daniel Hitt <[email protected]> [email protected] (Darran Edmundson) [email protected] David Krieger [email protected]> [email protected] (David A. Roth) [email protected] (David Stodolsky) [email protected] (Daniel Briggs) [email protected] (Dennis Montgomery) [email protected] (Don Garrett) Dieter Hoffmann <[email protected]> [email protected] (Dean Inada) Doug Platt <[email protected]> [email protected] (Bill Dyer) [email protected] (Ed Hew) Edd <[email protected]> [email protected] (Edgar W. Swank) Eric Hunt <[email protected]> [email protected] (Eric Messick) [email protected] [email protected] [email protected] (Frank Deming {x6088}) [email protected] [email protected] (Andrew Hall) Forrest H Bennett <[email protected]> foxxjac!foxx (Andrew "AJ" Foxx) Frank Blau <[email protected]> [email protected] (Franz G. Amador) Garret Smyth <[email protected]> [email protected] [email protected] (Hal Finney) Graham Wilson <[email protected]> [email protected] (Gregor Purdy) [email protected] (Harry Shapiro) Hank Lederer <[email protected]> Harvey Newstrom <[email protected]> [email protected] [email protected] (Herman Rubin) [email protected] [email protected] (John M. Abreau) Jack E. Wilkinson <[email protected]> [email protected] (Martin Janzen) [email protected] [email protected] (Jason Morris) jfg%[email protected] (Jean Francois Groff) [email protected] [email protected] (John E. Kreznar) [email protected] Joan Eslinger <[email protected]> JOE POTTS <[email protected]> [email protected] (Johan Strandberg) [email protected] [email protected] (John Gregor) Jon Leech <[email protected]> Joseph Troxel <[email protected]> [email protected] [email protected] (Richard Kennaway) [email protected] (Kari Dubbelman) "Karl M. Waldman" <[email protected]> [email protected] (Kim DeVaughn) "Keith F. Lynch" <[email protected]> Ken Kahn <[email protected]> [email protected] (Kevin Dalley) [email protected] [email protected] (Krishna Kunchithapadam) [email protected] (Trent Lange) Laura Gillespie <[email protected]> [email protected] Leonard N. Zubkoff <[email protected]> Lola McCrary <[email protected]> [email protected] [email protected] (David Lubkin) [email protected] (Andrew Patrick Booth) [email protected] (Salamander) Mark Edward Desilets <[email protected]> [email protected] (Mike McEwin) [email protected] (Matt Day) [email protected] (Michael Chastain) Michael Clive Price <[email protected]> Michael R Linksvayer <[email protected]> [email protected] (Michael McClary) [email protected] (Micheal B. O'Neal) [email protected] (Mike Carroll) [email protected] (Steve Mims) [email protected] (Miron S. Cuperman) [email protected] (Michael Massing) [email protected] (Mark Muhlestein) moose.heurikon.com!lampman%[email protected] (Ray Lampman) [email protected] (Bill Hartwell) [email protected] [email protected] [email protected] (Nathaniel Stitt) [email protected] (Noelie Alito) [email protected] (Ard Ri) [email protected] [email protected] (MICHAEL G KIELSKY) Paul Wakfer <[email protected]> [email protected] (Paul Johnson) [email protected] (Phil Howard ) Pete Boulay <[email protected]> Peter Alexander Merel <[email protected]> [email protected] (ph600fdd) [email protected] (Perry E. Metzger) [email protected] [email protected] [email protected] (Peter Westlake) Ralph Merkle <[email protected]> [email protected] [email protected] Ray Ingles <[email protected]> [email protected] (Ray F. Gasser) [email protected] [email protected] (Robert Cohen) "Richard Schroeppel" <[email protected]> [email protected] (Young Rob Jellinghaus) Rodney Alan Price <[email protected]> Ronald Hale-Evans <[email protected]> Ross Beresford <[email protected]> [email protected] (Erik Rossen) [email protected] (Ray Peck) [email protected] (Rich Thomson) "Russell E. Whitaker" <[email protected]> [email protected] (Richard W. Jamison) [email protected] (Alexander Chislenko) [email protected] (Thomas D. Shapard) [email protected] (Sharen A. Rund) [email protected] (Robert Sheaffer) Simon <[email protected]> [email protected] (Steve Jackson) [email protected] (Steven J. Edwards) [email protected] [email protected] (Steve Strong) "Stephen J. Whitrow" <[email protected]> Steve Bridge <[email protected]> Steve Coltrin <[email protected]> Steve Saunders <[email protected]> "Steven B. Harris" <[email protected]> "Steven N. Crane" <[email protected]> Stig Hemmer <[email protected]> [email protected] (Sascha Wildner) [email protected] (Steve E. Witham) The Juggler <[email protected]> [email protected] Thomas Gramstad <[email protected]> Thomas Hagadorn (LRAD/FRB) <[email protected]> Thomas Mc Kendree <[email protected]> [email protected] (Paul Schmidt) [email protected] (Tim Frost) [email protected] [email protected] [email protected] (Thomas Lee Bont) tolman%[email protected] (Kenneth Tolman) Tony Rogers <[email protected]> [email protected] (Terence P. Ma) [email protected] [email protected] (E. Dean Tribble) [email protected] (Russell Turpin) [email protected] [email protected] [email protected] (William Dye) [email protected] (Kiyoshi Kuromiya) [email protected] [email protected] Yasuki Saito <[email protected]>   No votes: [email protected] (Andrew Scott Beals -- KC6SSS) [email protected] (Baxter Garcia) [email protected] (Brian Hanafee) [email protected] (William F. Mullin) [email protected] (Bob Janssens) [email protected] (Barbara La Scala) Bob Snyder <[email protected]> Charles Platt <[email protected]> [email protected] (Charlie Chang) "Chris J. Davis" <[email protected]> davidb%[email protected] (David Brynell) [email protected] (Dave Joyce) [email protected] (David  Fenger) [email protected] (Ed Geraghty) [email protected] (Eileen Sipperley) [email protected] (John Foxe) George Kimeldorf <[email protected]> [email protected] (Matthias Imhof) Helge Hauglin <[email protected]> [email protected] (Henrik Klagges) [email protected] [email protected] (Hisashi Todd Fujinaka) [email protected] (Edward J. Huff) Jeff Schultz <[email protected]> [email protected] [email protected] (John F. Whitehead) Joel B Levin <[email protected]> [email protected] (No Exit) John G Dobnick <[email protected]> [email protected] [email protected] (Lori Spier) [email protected] [email protected] (Luigi Arena) [email protected] Marc Moorcroft <[email protected]> [email protected] (Malcolm Austin) [email protected] Mike Fessler <[email protected]> Norbert Bollow <[email protected]> [email protected] (Leonard J. Peirce) [email protected] (Bill Pugh) [email protected] (Richard E. Depew) [email protected] (Richard Harms) [email protected] (Richard H. Miller) [email protected] (David Rind) Robert Allan Zeh <[email protected]> "Rocky J. Jenkins" <[email protected]> [email protected] (R. P. White) Saul Tannenbaum <[email protected]> [email protected] (Janne Himanka) [email protected] (Tarl Neustaedter) "Timothy J. Allison" <[email protected]> [email protected] (Real life?  Ha!) [email protected] (Daniel R. Upper) Werner Uhrig <[email protected]> William Lewis <[email protected]> [email protected] (Gregory G. Woodbury) [email protected] (Norman Yarvin)   From [email protected] Wed Mar 19 09:15:10 1997 Path: news.isc.org!bounce-back From: Joseph Strout <[email protected]> Newsgroups: news.announce.newgroups,news.groups,sci.cryonics Subject: RFD: moderate sci.cryonics Followup-To: news.groups Message-ID: <[email protected]> Approved: [email protected] Archive-Name: sci.cryonics Date: Wed, 19 Mar 1997 17:00:36 GMT Lines: 93 Xref: news.isc.org news.announce.newgroups:210                       REQUEST FOR DISCUSSION (RFD)        moderated group sci.cryonics (moderates existing group)  This is a formal Request For Discussion (RFD) for changing the status of the existing group sci.cryonics from unmoderated to moderated. This is not a Call for Votes (CFV); you cannot vote at this time. Procedural details are below.  Newsgroup lines: sci.cryonics		Cryonics and related topics. (Moderated)  RATIONALE: sci.cryonics  The existing unmoderated group sci.cryonics has been suffering from a decreasing signal/noise ratio.  In addition to the usual cross-posted spam, there have been numerous personal attacks of a highly offensive nature posted from anonymous remailers, as well as forged messages apparently from legitimate members of the group.  This traffic is damaging to the members of the group, as well as to the cryonics community as a whole.  Changing the newsgroup from unmoderated to moderated should greatly reduce the volume of such messages, and so enhance the value of the group.  CHARTER: sci.cryonics  Cryonic suspension is an experimental procedure whereby patients who can no longer be kept alive with today's medical abilities are preserved at low temperature for treatment in the future.  This newsgroup will be the place to keep up-to-date on topics related to cryonics, which include biochemistry of memory, low temperature biology, new cryonics-related research and publications, legal status of cryonics and cryonically suspended people, nanotechnology and cell repair machines, mass media coverage of cryonics, conferences, and local cryonics group meetings.  Unacceptable messages include personal attacks, messages posted without a valid sender address, and any message not pertaining to the topics above.  END CHARTER.  MODERATOR INFO: sci.cryonics  Moderator:  Keith F. Lynch <[email protected]>               Keith has been active on the net for 20 years.  He is vice president of the Life Extension Society.  He maintains an indexed and cross- referenced archive of the Cryonet mailing list (he does not maintain the list itself, however).  Backup Moderator: Joseph J. Strout <[email protected]>                     Joe has been reading sci.cryonics and the CRYONET mailing list since 1993.  He is currently pursuing his Ph.D. in Neuroscience at the University of California, San Diego.  END MODERATOR INFO.  PROCEDURE:  This is a request for discussion, not a call for votes.  In this phase of the process, any potential problems with the proposed newsgroups should be raised and resolved.  The discussion period will continue for a minimum of 21 days (starting from when the first RFD for this proposal is posted to news.announce.newgroups), after which a Call For Votes (CFV) will be posted by a neutral vote taker.  Please do not attempt to vote until this happens.  All discussion of this proposal should be posted to news.groups.  This RFD attempts to comply fully with the Usenet newsgroup creation guidelines outlined in "How to Create a New Usenet Newsgroup" and "How to Format and Submit a New Group Proposal".  Please refer to these documents (available in news.announce.newgroups) if you have any questions about the process.  DISTRIBUTION:  This RFD has been posted to the following newsgroups:    news.announce.newgroups, news.groups,   sci.cryonics  and the following mailing list:    CryoNet (discussion of cryonics)       subscribe via <[email protected]>  - Proponent: Joe Strout <[email protected]> Mentor: Jonathan Grobe <[email protected]>  From [email protected] Thu May  8 07:23:04 1997 Path: news.isc.org!bounce-back From: David Bostwick <[email protected]> Reply-To: [email protected] Newsgroups: news.announce.newgroups,news.groups,sci.cryonics Subject: CFV: moderate sci.cryonics Followup-To: poster Message-ID: <86307[email protected]> References: <[email protected]> Supersedes: <[email protected]> Organization: Usenet Volunteer Votetakers Approved: [email protected] Expires: 30 May 1997 00:00:00 GMT Archive-Name: sci.cryonics Date: Thu, 08 May 1997 07:45:01 GMT Lines: 140 Xref: news.isc.org news.announce.newgroups:402                       FIRST CALL FOR VOTES (of 2)        moderated group sci.cryonics (moderates existing group)  Newsgroups line: sci.cryonics		Cryonics and related topics. (Moderated)  Votes must be received by 23:59:59 UTC, 29 May 1997.  This vote is being conducted by a neutral third party.  Questions about the proposed group should be directed to the proponent.  Proponent: Joe Strout <[email protected]> Mentor: Jonathan Grobe <[email protected]>  Votetaker: David Bostwick <[email protected]>  RATIONALE: sci.cryonics  The existing unmoderated group sci.cryonics has been suffering from a decreasing signal/noise ratio.  In addition to the usual cross-posted spam, there have been numerous personal attacks of a highly offensive nature posted from anonymous remailers, as well as forged messages apparently from legitimate members of the group.  This traffic is damaging to the members of the group, as well as to the cryonics community as a whole.  Changing the newsgroup from unmoderated to moderated should greatly reduce the volume of such messages, and so enhance the value of the group.  CHARTER: sci.cryonics  Cryonic suspension is an experimental procedure whereby patients who can no longer be kept alive with today's medical abilities are preserved at low temperature for treatment in the future.  This newsgroup will be the place to keep up-to-date on topics related to cryonics, which include biochemistry of memory, low temperature biology, new cryonics-related research and publications, legal status of cryonics and cryonically suspended people, nanotechnology and cell repair machines, mass media coverage of cryonics, conferences, and local cryonics group meetings.  Unacceptable messages include personal attacks, messages posted without a valid sender address, and any message not pertaining to the topics above.  END CHARTER.  MODERATOR INFO: sci.cryonics  Moderator: "Keith F. Lynch" <[email protected]> Administrative contact address: [email protected] Article submission address: [email protected]  END MODERATOR INFO.  GATEWAYS: sci.cryonics  Gateway mailing list name: CryoNet Submission address: [email protected] Request address: [email protected]  DISTRIBUTION:  Pointers directing readers to this CFV will be posted in these groups:  sci.life-extension sci.nanotech  IMPORTANT VOTING PROCEDURE NOTES:  Standard Guidelines for voting apply.  One person, one vote.  Votes must be mailed directly from the voter to the votetaker.  Anonymous, forwarded or proxy votes are not valid.  Votes mailed by WWW/HTML/CGI forms are considered to be anonymous votes.  Vote counting is automated.  Failure to follow these directions may mean that your vote does not get counted.  If you do not receive an acknowledgment of your vote within three days contact the votetaker about the problem.  It's your responsibility to make sure your vote is registered correctly.  Duplicate votes are resolved in favor of the most recent valid vote.  Addresses and votes of all voters will be published in the final voting results post.  The purpose of a Usenet vote is to determine the genuine interest of persons who would read a proposed newsgroup.  Soliciting votes from uninterested parties defeats this purpose.  Please do not distribute this CFV.  If you must, direct people to the official CFV as posted to news.announce.newgroups.  Distributing pre-marked or otherwise edited copies of this CFV is generally considered to be vote fraud. When in doubt, ask the votetaker.  HOW TO VOTE:  Extract the ballot from the CFV by deleting everything before and after the "BEGINNING OF BALLOT" and "END OF BALLOT" lines.  Don't worry about the spacing of the columns or any quote characters (">") that your reply inserts.  Please do not send the entire CFV back to me.  Fill in the ballot as shown below.  Please provde a valid name and indicate your desired vote in the appropriate locations inside the ballot.  When finished, MAIL the ballot to: [email protected] Just "replying" to this message should work, but check the "To:" line.  Examples of how to properly indicate your vote (do not vote here):    [ YES     ]  example.yes.vote   [ NO      ]  example.no.vote   [ ABSTAIN ]  example.abstention   [ CANCEL  ]  example.cancellation  DO NOT modify, alter or delete any information in this ballot! If you do, the voting software will probably reject your ballot.  If these instructions are unclear, please ask the votetaker.  ======== BEGINNING OF BALLOT: Delete everything before this line ======= .----------------------------------------------------------------------- | 1ST CALL FOR VOTES: sci.cryonics reorg | Official Usenet Voting Ballot  (Do not remove this line!) |----------------------------------------------------------------------- | Please provide a valid name, or your vote may be rejected.  Place | ONLY your name (i.e., do not include your e-mail address or any other | information) after the colon on the following line:  Voter name:  | Insert YES, NO, ABSTAIN, or CANCEL inside the brackets for each | newsgroup listed below (do not delete the newsgroup name):   Your Vote   Newsgroup  ---------   -----------------------------------------------------------  [       ]   sci.cryonics  ======== END OF BALLOT: Delete everything after this line ==============  This CFV was created with uvpq 1.0omega (May  6 1997). PQ datestamp: 970324  --  Voting address    : [email protected]  From [email protected] Tue May 20 18:15:07 1997 Path: news.isc.org!bounce-back From: David Bostwick <[email protected]> Reply-To: [email protected] Newsgroups: news.announce.newgroups,news.groups,sci.cryonics Subject: 2nd CFV: moderate sci.cryonics Followup-To: poster Message-ID: <[email protected]> References: <[email protected]> <[email protected]> Supersedes: <[email protected]> Organization: Usenet Volunteer Votetakers Approved: [email protected] Expires: 30 May 1997 00:00:00 GMT Archive-Name: sci.cryonics Date: Wed, 21 May 1997 01:01:09 GMT Lines: 140 Xref: news.isc.org news.announce.newgroups:433                        LAST CALL FOR VOTES (of 2)        moderated group sci.cryonics (moderates existing group)  Newsgroups line: sci.cryonics		Cryonics and related topics. (Moderated)  Votes must be received by 23:59:59 UTC, 29 May 1997.  This vote is being conducted by a neutral third party.  Questions about the proposed group should be directed to the proponent.  Proponent: Joe Strout <[email protected]> Mentor: Jonathan Grobe <[email protected]>  Votetaker: David Bostwick <[email protected]>  RATIONALE: sci.cryonics  The existing unmoderated group sci.cryonics has been suffering from a decreasing signal/noise ratio.  In addition to the usual cross-posted spam, there have been numerous personal attacks of a highly offensive nature posted from anonymous remailers, as well as forged messages apparently from legitimate members of the group.  This traffic is damaging to the members of the group, as well as to the cryonics community as a whole.  Changing the newsgroup from unmoderated to moderated should greatly reduce the volume of such messages, and so enhance the value of the group.  CHARTER: sci.cryonics  Cryonic suspension is an experimental procedure whereby patients who can no longer be kept alive with today's medical abilities are preserved at low temperature for treatment in the future.  This newsgroup will be the place to keep up-to-date on topics related to cryonics, which include biochemistry of memory, low temperature biology, new cryonics-related research and publications, legal status of cryonics and cryonically suspended people, nanotechnology and cell repair machines, mass media coverage of cryonics, conferences, and local cryonics group meetings.  Unacceptable messages include personal attacks, messages posted without a valid sender address, and any message not pertaining to the topics above.  END CHARTER.  MODERATOR INFO: sci.cryonics  Moderator: "Keith F. Lynch" <[email protected]> Administrative contact address: [email protected] Article submission address: [email protected]  END MODERATOR INFO.  GATEWAYS: sci.cryonics  Gateway mailing list name: CryoNet Submission address: [email protected] Request address: [email protected]  DISTRIBUTION:  Pointers directing readers to this CFV will be posted in these groups:  sci.life-extension sci.nanotech  IMPORTANT VOTING PROCEDURE NOTES:  Standard Guidelines for voting apply.  One person, one vote.  Votes must be mailed directly from the voter to the votetaker.  Anonymous, forwarded or proxy votes are not valid.  Votes mailed by WWW/HTML/CGI forms are considered to be anonymous votes.  Vote counting is automated.  Failure to follow these directions may mean that your vote does not get counted.  If you do not receive an acknowledgment of your vote within three days contact the votetaker about the problem.  It's your responsibility to make sure your vote is registered correctly.  Duplicate votes are resolved in favor of the most recent valid vote.  Addresses and votes of all voters will be published in the final voting results post.  The purpose of a Usenet vote is to determine the genuine interest of persons who would read a proposed newsgroup.  Soliciting votes from uninterested parties defeats this purpose.  Please do not distribute this CFV.  If you must, direct people to the official CFV as posted to news.announce.newgroups.  Distributing pre-marked or otherwise edited copies of this CFV is generally considered to be vote fraud. When in doubt, ask the votetaker.  HOW TO VOTE:  Extract the ballot from the CFV by deleting everything before and after the "BEGINNING OF BALLOT" and "END OF BALLOT" lines.  Don't worry about the spacing of the columns or any quote characters (">") that your reply inserts.  Please do not send the entire CFV back to me.  Fill in the ballot as shown below.  Please provde a valid name and indicate your desired vote in the appropriate locations inside the ballot.  When finished, MAIL the ballot to: [email protected] Just "replying" to this message should work, but check the "To:" line.  Examples of how to properly indicate your vote (do not vote here):    [ YES     ]  example.yes.vote   [ NO      ]  example.no.vote   [ ABSTAIN ]  example.abstention   [ CANCEL  ]  example.cancellation  DO NOT modify, alter or delete any information in this ballot! If you do, the voting software will probably reject your ballot.  If these instructions are unclear, please ask the votetaker.  ======== BEGINNING OF BALLOT: Delete everything before this line ======= .----------------------------------------------------------------------- | LAST CALL FOR VOTES: sci.cryonics reorg | Official Usenet Voting Ballot  (Do not remove this line!) |----------------------------------------------------------------------- | Please provide a valid name, or your vote may be rejected.  Place | ONLY your name (i.e., do not include your e-mail address or any other | information) after the colon on the line below:  Voter name:  | Insert YES, NO, ABSTAIN, or CANCEL inside the brackets for each | newsgroup listed below (do not delete the newsgroup name):   Your Vote   Newsgroup  ---------   -----------------------------------------------------------  [       ]   sci.cryonics  ======== END OF BALLOT: Delete everything after this line ==============  This CFV was created with uvpq 1.0omega (May  6 1997). PQ datestamp: 970324  --  Voting address    : [email protected]  From [email protected] Mon Jun  2 13:30:10 1997 Path: news.isc.org!bounce-back From: David Bostwick <[email protected]> Reply-To: [email protected] Newsgroups: news.announce.newgroups,news.groups,sci.cryonics Subject: RESULT: moderate sci.cryonics fails 70:31 Followup-To: news.groups Message-ID: <[email protected]> References: <[email protected]> <[email protected]> <[email protected]> Supersedes: <[email protected]> Organization: Usenet Volunteer Votetakers Approved: [email protected] Archive-Name: sci.cryonics Date: Mon, 02 Jun 1997 20:17:32 GMT Lines: 199 Xref: news.isc.org news.announce.newgroups:478                                  RESULT  moderated group sci.cryonics (moderates existing group) fails 70:31  There were 70 YES votes and 31 NO votes, for a total of 101 valid votes. There was 1 abstain and 3 invalid ballots.  For group passage, YES votes must be at least 2/3 of all valid (YES and NO) votes.   There also must be at least 100 more YES votes than NO votes.  There is a five day discussion period after these results are posted. Unless serious allegations of voting irregularities are raised, the group may not be voted on again for six months.  Newsgroups line: sci.cryonics		Cryonics and related topics. (Moderated)  The voting period ended at 23:59:59 UTC, 29 May 1997.  This vote was conducted by a neutral third party.  Questions about the proposed group should be directed to the proponent.  Proponent: Joe Strout <[email protected]> Mentor: Jonathan Grobe <[email protected]>  Votetaker: David Bostwick <[email protected]>  RATIONALE: sci.cryonics  The existing unmoderated group sci.cryonics has been suffering from a decreasing signal/noise ratio.  In addition to the usual cross-posted spam, there have been numerous personal attacks of a highly offensive nature posted from anonymous remailers, as well as forged messages apparently from legitimate members of the group.  This traffic is damaging to the members of the group, as well as to the cryonics community as a whole.  Changing the newsgroup from unmoderated to moderated should greatly reduce the volume of such messages, and so enhance the value of the group.  CHARTER: sci.cryonics  Cryonic suspension is an experimental procedure whereby patients who can no longer be kept alive with today's medical abilities are preserved at low temperature for treatment in the future.  This newsgroup will be the place to keep up-to-date on topics related to cryonics, which include biochemistry of memory, low temperature biology, new cryonics-related research and publications, legal status of cryonics and cryonically suspended people, nanotechnology and cell repair machines, mass media coverage of cryonics, conferences, and local cryonics group meetings.  Unacceptable messages include personal attacks, messages posted without a valid sender address, and any message not pertaining to the topics above.  END CHARTER.  MODERATOR INFO: sci.cryonics  Moderator: "Keith F. Lynch" <[email protected]> Administrative contact address: [email protected] Article submission address: [email protected]  END MODERATOR INFO.  GATEWAYS: sci.cryonics  Gateway mailing list name: CryoNet Submission address: [email protected] Request address: [email protected]  DISTRIBUTION:  Pointers directing readers to this CFV were posted in these groups:  sci.life-extension sci.nanotech  sci.cryonics Final Vote Ack  Voted Yes ------------------------------------------------------------------------------ [email protected]                                          Paul Wakfer [email protected]                                Albert-Jan Brouwer [email protected]                                        D=E1maso D. Est=E9vez [email protected]                                           Andre Robatino [email protected]                                         Stephanie da Silva [email protected]                                 Alistair J. R. Young [email protected]                                                  Baird Stafford [email protected]                                              Bill Burns [email protected]                                                Brian Hillegass [email protected]                                             Ken Butler [email protected]                                      Chris Stone [email protected]                                          David A. Howard [email protected]                                                  Chris Koenigsberg [email protected]                                                     Charles Platt [email protected]                                      Christopher M. Rasch [email protected]                                         Randall C. Smith [email protected]                                             Daniel Jacobs [email protected]                                            DeadLock the Feral [email protected]                                            David desJardins [email protected]                                               David C. Harris [email protected]                                                 Mike Dugger [email protected]                                     Brennan T. Price [email protected]                                             Eli Brandt [email protected]                                  Eugene Leitl [email protected]                                              Ekkehard Uthke [email protected]                                        Gregory R. Paddock [email protected]                                                  Harvey Newstrom [email protected]                                     Jim Baranovich [email protected]                                             Iain Whitehead [email protected]                                               Jasmine Taylor [email protected]                                        J.D. Falk [email protected]                           John David Galt [email protected]                                         J. Porter Clark [email protected]                                              Joseph J. Strout [email protected]                                      Kenneth B Storey [email protected]                                                  Kim DeVaughn [email protected]                                          Karel William Sebek [email protected]                                             Jukka A. Lung [email protected]                                              Mark O'Leary [email protected]                                                  Mike Hatz [email protected]                                Christian Weisgerber [email protected]                             Nick Waterman likes short ballots [email protected]                                               Jules Dubois [email protected]                                              William Miller [email protected]                                           Anders Sandberg [email protected]                                       Patrick Wilken [email protected]                                              Trevor Tymchuk [email protected]                                                  Peter McCluskey [email protected]                                            Perry E. Metzger [email protected]                                               Peter da Silva [email protected]                                                Robert Alan Mole [email protected]                                           Richard Songhurst [email protected]                                          H. Albert Rosman [email protected]                                             J Rufinus [email protected]                                                  Steve Coltrin [email protected]                                      Srdjan B. Stakic [email protected]                                    Stephen Van Sickle [email protected]                                                           Ryan [email protected]                                                  Tom Matthews [email protected]                                                    Tony Basoglu [email protected]                                              Tshen [email protected]                                                  Tim Skirvin [email protected]                                                   Will Dye [email protected]                                        William McClain [email protected]                                                Brian Wowk [email protected]                                                  Will Ware [email protected]                                   Craig Wyllie [email protected]                                                 Ned Fleming [email protected]                                                  Mark Atwood [email protected]                                              L. MARIE MILLER  Voted No ------------------------------------------------------------------------------ [email protected]                                          Aaro Koskinen [email protected]                                             Martin H. Booda [email protected]                                                  David W. Crawford [email protected]                                                Bruce White [email protected]                                      John W. Andrews [email protected]                                                Olivier Devuns [email protected]                                             David L. Hanson [email protected]                                         Geoff Keating [email protected]                                           G.P. Ryan [email protected]                                             Henry Fung [email protected]                                                   Henrietta Thomas [email protected]                                                Igor Chudov [email protected]                                                 Keith Adams [email protected]                                             Jeremiah Blatz [email protected]                                          Joshua Kramer [email protected]                            jon ivar skullerud [email protected]                                           Lewis McCarthy [email protected]                                              Aaron Marquez [email protected]                                 Mustafa Soysal MS57 [email protected]                                          Nick Ingegneri [email protected]                                             Olav Nieuwejaar [email protected]                                           Patrick J. LoPresti [email protected]                                                Richard Miller [email protected]                                                      Bob blanchard [email protected]                                                   John Savard [email protected]                                  Wolfgang Schelongowski [email protected]                                                  Dwight Brown [email protected]                                              Chris Stamper [email protected]                                            Jason Steiner [email protected]                                     Stuart Yeates [email protected]                                                Todd C. Lawson  Abstained ------------------------------------------------------------------------------ [email protected]                                                Guy Macon   Votes in error ------------------------------------------------------------------------------ [email protected]    ! No name given [email protected]                                                furrball    ! Invalid address [email protected]    ! No name given 
 
USENET FACT: Flaming
Flaming is the hostile interaction between multiple Usenet users.
 
Menu